Back to News

Posted
February 16, 2024

Bi-partisan bill in Ohio House aims to cap prices on insulin

A bipartisan bill filed last week by two Ohio House lawmakers would cap out-of-pocket costs for insulin and devices used in the treatment of diabetes (Source: “Bipartisan Ohio House bill seeks to lower insulin costs,” Ohio Capital Journal, Feb. 15).

The move comes after the Biden administration in 2022 capped costs for Medicare patients, and after the big manufacturers themselves have begun taking steps to bring down prices.

The bill, cosponsored by Reps. Munira Abdullahi, D-Columbus, and Thomas Hall, R-Madison Township, would cap out-of-pocket insulin costs for all Ohioans at $35 a month. It also would cap the cost of related devices such as test strips, syringes and insulin pumps at $100 a month.

Hall and Abdullahi realized they’re both diabetic when they saw each other treating their conditions in the members’ lounge in the Capitol, Hall said during a press conference last week. That’s when they decided to work together to bring down costs.

Attend HPIO's 2025 Health Policy Summit on Oct. 9, 2025

With limited resources and growing need, investing in policies that deliver the greatest impact is essential. This event will highlight strategies that improve health and wellbeing while reducing healthcare spending. Speakers will provide evidence-informed research responsive to today’s political climate, focusing on what works and why it matters now more than ever.

Register now